Book Navigation
x

We are sorry, but signing in with LinkedIn is not possible at this time.

 

Jorma Komulainen, MD, PhD

Member of the G-I-N Board of Trustees 2012/2013 and 2013/14

Jorma Komulainen, adjunct professor, editor-in-chief in Current Care guidelines, Finnish Medical Society Duodecim, Helsinki, Finland.

My background is in paediatric endocrinology, with which I have around 25 years experience from working as a clinical practitioner. Although during the last decade, I have been active in other than clinical fields, I still see myself as a clinical physician, and continue part-time practice with my patients. My scientific work mainly consists of original publications in the fields of diabetes, paediatric endocrinology, and health informatics. In addition, I have been one of the writers of altogether 15 Finnish national evidence-based Current Care clinical practise guidelines.

In 2003, I became involved in the world of guidelines as a part-time editor in the Current Care. A few years later I was nominated as the development manager. This was an interesting task, which included management of EBMeDS (Evidence Based Medicine electronic Decision Support) development project between 2006-2008. After working as a senior medical officer in the National Institute for Health and Welfare between 2008-2011, I took my current post as the editor-in-chief of Current Care guidelines in the spring of 2011.

Since the meeting in Lyon, I have participated in most of the G-I-N congresses with abstracts, oral presentations and workshops. In the Helsinki meeting in 2008, I was a member of the scientific committee as well as the organising committee. I have also become involved in the G-I-N Evidence Tables working group.

The Finnish Medical Society Duodecim is a founding member of G-I-N. We have produced national clinical evidence-based guidelines since 1995. At the moment, we are strongly developing the role of rehabilitation in our guidelines, as well as developing tools for implementation of the guidelines.

Vision for G-I-N over the next 5 years

G-I-N is a network for clinical practice guideline development, dissemination, implementation and evaluation. A good network consists of different people and organisations, with different opinions. G-I-N continues to be an open forum for sharing ideas and experiences, not for setting regulations and standards.

Producing clinical practice guidelines is costly and requires a lot of effort. While many of the guidelines are likely to stay local or national, critically appraised evidence can, and should be shared. G-I-N will continue the development of tools, such as GINDER, for sharing this evidence.

On many occasions, even entire guidelines can be localised. G-I-N will actively search contacts in developing countries, to help these countries to either produce their own clinical practise guidelines, or to localise guidelines produced elsewhere.

Information technology offers many potential tools for guideline implementation. G-I-N will offer a forum for IT-developers to share ideas and to plan future cooperation.

 

  • Implementation

    The primary purpose of the Implementation Working Group (IWG) is to build capacity for guideline implementation. To do so, the IWG will progress the science of guideline implementation by generating knowledge and associated outputs/products on how to plan, undertake, enable and evaluate guideline implementation. It will also promote the practice of guideline implementation by generating and sharing knowledge and tools, and organising and offering training opportunities.

  • AID Knowledge

    Rapid knowledge appraisal methods in COVID-19 times, G-I-N AID Knowledge The speed at which guidance needs to be produced during the Covid-19 outbreak poses a huge challenge to guidance producing bodies around the globe. Outbreak guidance is known for the need to be ‘fast but right’, but now that Covid-19 is affecting health systems, including other parts of clinical care, primary care, long-term care, care for ageing adults, mental health care, and many more, guidance for a wide range of sectors is being developed at a fraction of the time that is usually required. This poses an acute challenge: how to appraise and include wide ranging types of knowledge to come to robust guidance in the absence of frequentist (RCT-based) evidence? How to do so without resorting to expert opinion without empirical checks-and-balances? And how to balance harms, benefits and efficiencies, especially when already marginalized communities risk paying the highest price? The working group on Appraising and Including Different Knowledge (AID Knowledge) https://g-i-n.net/working-groups/aid-knowledge of the Guidelines International Network (G-I-N) is launching two initiatives to inventory methods deployed and provide peer support in producing rapid guidance. It will run 1) inventory current methods and approaches for rapid knowledge appraisal and inclusion, as predominantly used by G-I-N members and will 2) run several webinars/workshops for guidance developers where leaders from different care sectors give short presentations, followed by peer support for challenges raised in break-out rooms. These initiatives serve the dual aim of 1) providing current support to those developing guidance under unprecedented conditions and 2) inventorying methods that, though used now, may impact the future of guideline development. Already guideline developing bodies are reflecting on how these rapid approaches will impact their practices in future. Where ‘rapid guidance’ was still a niche in guideline development, where most guidelines take years to develop, this is likely to change due to Covid-19. If it does, knowledge appraisal methods that are rapid but also robust need to be documented. Now is the time to do so. If you are interested in joining the webinars/workshops, please contact Teun Zuiderent-Jerak: teun.zuiderent-jerak@vu.nl A recording of the webinar "Which crisis? Whose evidence? Robust and inclusive evidence for rapid outbreak guidance" can is available under the COVID-19 tab.

Page last updated: Feb 13, 2020
Back to top